Search Nonprofits

ASK is a 501(c)(3) organization founded in 1975 by a small group of parents whose children had cancer. They came together to provide mutual support, search for answers, and deal with the devastating news no parent ever wants to hear: “Your child has cancer.” With 1-2 children diagnosed per week in Central VA, your donation will be a great help to our small, local nonprofit dedicated to making life better for children with cancer. Your support will help to provide emotional, social, financial and educational care to children with cancer who are treated at the Children’s Hospital of Richmond at VCU, the only treatment facility for childhood cancer in Central Virginia. ASK provides children, siblings, and caregivers with support from the moment of diagnosis through treatment to survivorship or bereavement.

Mission: To accelerate breakthroughs in lifesaving research and empower people everywhere to conquer cancer. Vision: Building a world where cancer is prevented or cured, and every survivor is healthy.

KrabbeConnect's mission is to be the source of comprehensive information and access to resources for patients with Krabbe disease. The foundation will drive state of the art research by bridging the gap between science and patient knowledge. The organization seeks to revolutionize the practice of medicine by identifying, optimizing, and implementing advances in the care and cure of globoid cell leukodystrophy, utilizing a multicenter network.

The mission of the Melanoma Research Alliance (MRA) is to end suffering and death due to melanoma by collaborating with all stakeholders to accelerate powerful research, advance cures for all patients, and prevent more melanomas.

The mission of the Neuroendocrine Tumor Research Foundation is to fund research to discover cures and more effective treatments for carcinoid, pancreatic, and related neuroendocrine cancers. To achieve rapid discovery of cures, the NET Research Foundation directs its donations to fund breakthrough scientific research of neuroendocrine cancers. Since its inception, the NET Research Foundation has awarded over $22 million in large-scale, multi-year research grants to leading scientists at renowned research institutions. The NET Research Foundation is committed to improving the lives of patients, families, and caregivers affected by neuroendocrine cancer by providing information and educational resources.

See details under EIN 13-1924236

AT MIGGY'S GIFT WE BRING HOPE, ENCOURAGEMENT, AND BRAVERY TO PEDIATRIC CANCER PATIENTS AND THEIR FAMILIES. HELPING CHILDREN IS AT THE FOREFRONT OF WHAT WE DO THROUGH OUR MIGHTY MIGGY PROJECT, EDUCATION AND AWARENESS PROGRAM, AND COLLEGE SCHOOL GRANTS.

Empowering those who have been diagnosed with breast cancer while advocating for their emotional and financial wellness. F/K/A Pink Warrior Angels Hill Country

A joint commitment to raise money for research and patient care with the mission of finding a cure for, or the means to control, cancer.

Cancer for College provides need-based college scholarships and educational experiences to cancer survivors.

The Jonsson Cancer Center Foundation (JCCF) was founded in 1945 by a group of volunteers dedicated to cancer research at UCLA. Their idea, using funds raised from private sources to invest in the work of promising young cancer researchers, resulted in the Seed Grant Program, which has helped the Jonsson Comprehensive Cancer Center (JCCC) break new ground in the quest to defeat cancer.

To make all who are touched by invasive lobular breast cancer (also referred to as invasive lobular carcinoma or “ILC”) aware of its unique characteristics and the critical need for more ILC research; to be the go-to source for information on ILC studies, clinical trials and educational tools; to foster partnerships among patients, scientists, clinicians, and breast cancer organizations to increase dialogue about ILC and research advocacy; and to fund vital ILC research. We envision a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently.